Literature DB >> 25815738

Noninvasive assessment of hemodynamics: a comparative analysis of fingertip pulse contour analysis and impedance cardiography.

Katherine A Sauder1, Paige E Pokorney, Cindy E McCrea, Jan S Ulbrecht, Penny M Kris-Etherton, Sheila G West.   

Abstract

OBJECTIVE: Systemic hemodynamic assessment is useful for characterizing the underlying physiology of hypertension, selecting individualized treatment approaches, and understanding the underlying mechanisms of action of interventions. Invasive methods are not suitable for routine clinic or research use, and noninvasive methods such as impedance cardiography have technical and practical limitations. Fingertip pulse contour analysis using the Nexfin device is a novel alternative to noninvasive assessment of blood pressure and hemodynamics. Although both impedance cardiography and the Nexfin have been validated against invasive methods, the extent to which they are correlated with each other is unknown. This study is a comparative analysis of data simultaneously obtained by impedance cardiography and using the Nexfin device.
METHODS: As part of a larger clinical trial, 13 adults with type 2 diabetes completed cardiovascular reactivity testing on three occasions: at study baseline and after two 4-week dietary treatment periods. Blood pressure, hemodynamics, and heart rate variability were assessed at rest and during acute mental stress.
RESULTS: Blood pressure, heart rate, and heart rate variability data were significantly correlated between the two devices, but hemodynamic data (stroke volume, cardiac output, total peripheral resistance) were not significantly correlated. Both techniques detected treatment-related changes in blood pressure and total peripheral resistance, but significantly differed in the magnitude and/or direction of treatment effects.
CONCLUSION: We conclude that Nexfin is not an appropriate alternative to impedance cardiography for measurement of underlying hemodynamics in psychophysiological research, but may be useful for beat-to-beat monitoring of blood pressure and heart rate variability.
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25815738      PMCID: PMC4496278          DOI: 10.1097/MBP.0000000000000118

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  23 in total

1.  Noninvasive blood pressure measurement by the Nexfin monitor during reduced arterial pulsatility: a feasibility study.

Authors:  Jerson R Martina; Berend E Westerhof; Jeroen Van Goudoever; Nicolaas De Jonge; Johannes J Van Lieshout; Jaap R Lahpor; Bas A J M De Mol
Journal:  ASAIO J       Date:  2010 May-Jun       Impact factor: 2.872

2.  Continuous non-invasive blood pressure monitoring, a validation study of Nexfin in a pregnant population.

Authors:  J Akkermans; M Diepeveen; W Ganzevoort; G A van Montfrans; B E Westerhof; H Wolf
Journal:  Hypertens Pregnancy       Date:  2009-05       Impact factor: 2.108

3.  Cardiac autonomic function and incident coronary heart disease: a population-based case-cohort study. The ARIC Study. Atherosclerosis Risk in Communities Study.

Authors:  D Liao; J Cai; W D Rosamond; R W Barnes; R G Hutchinson; E A Whitsel; P Rautaharju; G Heiss
Journal:  Am J Epidemiol       Date:  1997-04-15       Impact factor: 4.897

4.  Paced auditory serial-addition task: a measure of recovery from concussion.

Authors:  D M Gronwall
Journal:  Percept Mot Skills       Date:  1977-04

5.  Non-invasive measurement of pulse pressure variation and systolic pressure variation using a finger cuff corresponds with intra-arterial measurement.

Authors:  B Lansdorp; D Ouweneel; A de Keijzer; J G van der Hoeven; J Lemson; P Pickkers
Journal:  Br J Anaesth       Date:  2011-06-23       Impact factor: 9.166

Review 6.  Principles and techniques of blood pressure measurement.

Authors:  Gbenga Ogedegbe; Thomas Pickering
Journal:  Cardiol Clin       Date:  2010-11       Impact factor: 2.213

7.  Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study.

Authors:  H Tsuji; M G Larson; F J Venditti; E S Manders; J C Evans; C L Feldman; D Levy
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

8.  Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Circulation       Date:  2005-02-08       Impact factor: 29.690

Review 9.  Noninvasive continuous hemodynamic monitoring.

Authors:  Jasper Truijen; Johannes J van Lieshout; Wilbert A Wesselink; Berend E Westerhof
Journal:  J Clin Monit Comput       Date:  2012-06-14       Impact factor: 2.502

10.  Noninvasive cardiac output and blood pressure monitoring cannot replace an invasive monitoring system in critically ill patients.

Authors:  John F Stover; Reto Stocker; Renato Lenherr; Thomas A Neff; Silvia R Cottini; Bernhard Zoller; Markus Béchir
Journal:  BMC Anesthesiol       Date:  2009-10-12       Impact factor: 2.217

View more
  2 in total

1.  Cardiac autonomic function in patients with early multiple sclerosis.

Authors:  Richard Imrich; Miroslav Vlcek; Adela Penesova; Zofia Radikova; Andrea Havranova; Monika Sivakova; Pavel Siarnik; Branislav Kollar; Tomas Sokolov; Peter Turcani; Eva Heckova; Gilbert Hangel; Bernhard Strasser; Wolfgang Bogner
Journal:  Clin Auton Res       Date:  2021-03-04       Impact factor: 4.435

2.  Elevated Heart Rate and Pain During a Cold Pressor Test Correlates to Pain Catastrophizing.

Authors:  Gabriel Kakon; Amir-Arshiya Kaffash Mohamadi; Natalie Levtova; Meagane E I Maurice-Ventouris; Emilie-Anne Benoit; Florian Chouchou; Peter J Darlington; Geoffrey Dover
Journal:  Appl Psychophysiol Biofeedback       Date:  2021-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.